Category Archives: Tms

WASHINGTON, D.C. New findings from studies in both people and animals are revealing clues about how sensory information and cognitive processes interact in the brain to produce our perception of the world. The findings were presented at Neuroscience 2021, the annual meeting of the Society for Neuroscience and the worlds largest source of emerging news about brain science and health.

Sensory inputs, such as sights, sounds, and touches, yield rich information about the external world. But our perception and interpretation of sensations are heavily shaped by cognitive processes such as attention, expectation, and memory. A better understanding of the neural basis of perceptual phenomena will help clarify both ordinary experiences such as the ability to pick a single voice out of a noisy background and disorders in which perception is altered such as attention-deficit/hyperactivity disorder, autism, schizophrenia, and Alzheimers disease.

Todays new findings show:

The neuroscience findings presented today demonstrate the importance of comparative brain studies in long-standing issues in human perception and cognition, said Sabine Kastner, a professor at Princeton University who studies visual perception and attention. These advances show how research in different model systems can come together to inform our understanding of the human brain, from the neurobiological mechanisms of perception to our subjective perceptual experiences.

This research was supported by national funding agencies including the National Institutes of Health and private funding organizations. Find out more about sensory perception and the brain on BrainFacts.org.

Mechanisms of Perception Press Conference Summary

PV Neurons Enhance Cortical Coding in the Cocktail Party Problem

Kamal Sen, kamalsen@bu.edu, Abstract P442.10

Body Ownership and the Neural Processes of Memory Encoding and Reinstatement

Heather Iriye, heather.iriye@ki.se, Abstract P505.02

The Neural Bases of Simulation in the Primate Brain

David Sheinberg, David_Sheinberg@brown.edu, Abstract P775.01

Closed-loop EEG-TMS Modulation of Frontal-occipital Communication Enhances Visual Perception

Nitzan Censor, censornitzan@tauex.tau.ac.il, Abstract P767.09

###

About the Society for Neuroscience

The Society for Neuroscience is the world's largest organization of scientists and physicians devoted to understanding the brain and nervous system. The nonprofit organization, founded in 1969, now has nearly 37,000 members in more than 90 countries and over 130 chapters worldwide.

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.

See the original post:

How does the brain create our perception of reality? - EurekAlert

New Treatment Center Will Offer Comprehensive Drug and Alcohol Addiction Treatments in the Heart of Miami

November 8 2021 GIA Miami is proud to announce the official opening of its sister clinic, Vita Recovery, a sophisticated partial hospitalization program (PHP) and intensive outpatient program (IOP) facility specially designed to treat drug and alcohol addiction. The new center is located at 1501 Biscayne Blvd, Suite 203 in Miami. On October 4, 2021, a grand opening celebration was held to showcase its 5,000 square foot treatment facility, programs, and introduce its certified staff of diverse, international and multidisciplinary mental wellness experts to the South Florida mental health community, and to patients. The clinic is led by Dr. Anto Bonci and Francesco Del Governatore, Executive Chairman and CEO of Vita Recovery.

In an effort to address the communitys growing substance abuse crisis, GIA Miami owners, Dr. Anto Bonci, Roberto Ciapparelli, and Francesco Del Governatore launched Vita Recovery to provide concierge, personalized, and comprehensive wellness programs for adults 18 years and older dealing with drug and alcohol addiction. Vita Recovery combines physical, mental and spiritual practices with modern neuroscience, psychology and psychiatry to help ensure that clients get the most out of treatment and achieve their wellness goals.GIAs practice is built on using highly effective Transcranial Magnetic Stimulation (TMS) as a treatment method for mental issues such as depression, anxiety and substance abuse. Vita Recovery will offer more intensive, specially structured outpatient and partial hospitalization programs designed to help those suffering from drug and alcohol addiction. The two clinics will be co-located.The COVID-19 pandemic worsened incidences of drug and alcohol use, addiction, and overdose rates, which led us to open Vita Recovery in addition to GIA Miami, to provide the most innovative addiction treatments in an outpatient setting under one roof, said Dr. Anto Bonci, Executive Chairman and Founder of GIA Miami. Vita Recovery sets itself apart by bringing together a concierge approach to rehabilitation treatment, which is tailored to each patients social and emotional needs, added Bonci.

Both the PHP and IOP at Vita Recovery provide individually tailored and personalized care for each and every unique client. The programs at Vita Recovery are designed to recognize that mental wellness requires a comprehensive, holistic brain-body approach.

Therapy Programs:The intensive outpatient program (IOP) at Vita Recovery offers three hours of clinical services per day, four days per week. Vitas IOP also involves individual and group therapy and therapeutic activities, including outdoor meetings, beach and botanical garden trips, as well as Yoga and strength training with certified instructors. Vitas IOP can be a step down from detox, residential treatment programs or PHP.The PHP at Vita Recovery provides six hours of clinical services per day, five days per week. Vitas PHP involves individual and group therapy, psychiatric consultations, and fun therapeutic activities such as outdoor meetings, beach trips, meditation in the park, botanical garden visits, and yoga and strength training with certified instructors. The PHP at Vita Recovery can serve as a step down from detox or residential treatment programs when a client is ready for less intensive care or it can be a step up from an outpatient program when a client may need more structure or a higher level of care.Vita Recovery is now accepting admissions to its partial hospitalizations (PHP) and intensive outpatient programs (IOP). For more information, please visit vitarecovery.com or call (305)-707-0047.

About Vita Recovery and GIA Miami:

Vita Recovery and GIA Miami are multidisciplinary treatment centers based out of Miami, FL which are committed to helping patients dealing with various addiction and mental health issues. Founded in 2020, GIA Miami is a state-of-the-art Transcranial Magnetic Stimulation (TMS) and mental wellness center dedicated to offering this revolutionary treatment method to those suffering from various mental health disorders, such as anxiety, substance abuse, and depression. Vita Recovery, the sister clinic to GIA Miami, launched in the fall of 2021 and focuses on intensive outpatient programs and partial hospitalization for patients dealing with drug and alcohol abuse through a comprehensive system of treatments. GIA Miami is part of a larger healthcare group, which also includes Brain & Care by GIA Miami (www.brainandcare.com) present in the European market. For more information visit http://www.GIA.miami and vitarecovery.com.

See the original post:

Vita Recovery Celebrates Grand Opening of Its Miami Clinic - Florida Hospital News and Healthcare Report - South Florida Hospital News

Global TMS (Transcranial Magnetic Stimulation) Coil Market Growth 2021-2026 added by MRInsights.biz aims to provide a focused analysis of the data and facts with the underlying opportunity for clients to understand this and grow in the market through every detailed analysis in the report. Besides, this research helps product owners to understand the changes in the target market. The report then includes an elaborative summary of the global TMS (Transcranial Magnetic Stimulation) Coil market that provides in-depth knowledge of various segments of the market and future prospects for the 2021 to 2026 time period. The report focuses on the emerging trends in the global and regional spaces on all the significant components, such as market capacity, demand and supply, production, profit, and competitive landscape.

The research evaluates the market size, growth scenario, potential opportunities, trend analysis, and competitive analysis of the global TMS (Transcranial Magnetic Stimulation) Coil market. The report sorts the worldwide market to gauge the income and investigate the patterns in every one of the accompanying sub-markets: bases on the kind, by application, by end-clients, side-effect classification, and methodology, in view of geology and so on. It provides important information such as market growth, including the drivers, restraints, lucrative opportunities, industry-specific challenges, and recent.

NOTE: Our report highlights the major issues and hazards that companies might come across due to the unprecedented outbreak of COVID-19.

DOWNLOAD FREE SAMPLE REPORT: https://www.mrinsights.biz/report-detail/256092/request-sample

Moreover, the report provides additional information such as interesting insights, key industry developments, detailed segmentation of the market, a list of prominent players operating in the market, and other global TMS (Transcranial Magnetic Stimulation) Coil market trends. The study then discusses the alternative paths to business market customers, the critical role of industrial distributors and manufacturers representatives in marketing channels, the central components of channel design, and the requirement of successful channel strategy. The market report also provides the list of leading competitors along with the strategic insights and analysis of the key factors influencing the global TMS (Transcranial Magnetic Stimulation) Coil industry.

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the global TMS (Transcranial Magnetic Stimulation) Coil market:

What is the product type covered in the market?

What are the end users/application covered in the market?

Which regions are covered and what are the market trends in these regions?

ACCESS FULL REPORT: https://www.mrinsights.biz/report/global-tms-transcranial-magnetic-stimulation-coil-market-growth-256092.html

Customer Analysis:

The global TMS (Transcranial Magnetic Stimulation) Coil market report includes customer expectation of new product and service, customer perception of new product and service, understanding customer requirement, building customer relationship for new players, product and service recovery, product and service innovation and design, customer define product and service standards, delivering and performing product and service, customer role in product and service. It analyzes consumer perception and positioning, persuading consumers behavior and cross-cultural consumer behavior.

Customization of the Report:

This report can be customized to meet the clients requirements. Please connect with our sales team ([emailprotected]), who will ensure that you get a report that suits your needs. You can also get in touch with our executives on +1-201-465-4211 to share your research requirements.

Contact UsMark StoneHead of Business DevelopmentPhone: +1-201-465-4211Email: [emailprotected]Web: http://www.mrinsights.biz

Other Related Reports:

Global Natural Gas Storage Service Market 2021 Status and Outlook, Future Estimations with Top Key Players, Application and Segmentation by 2027

Global Reconfigurable Optical Add/Drop Multiplexing(ROADM) Market 2021 Development Status, Potential Growth, Share, and Analysis of Key Players 2027

Global Cable Laying Ship Market 2021 Analytical Assessment, Segments Analysis, Classifications and Competitive Landscape Analysis by 2027

Global Marine Boiler and Steam Turbine Generator Market 2021 Top Countries Data, Industry Growth Analysis, Future Demand and Leading Players by 2027

Global Electronic Boron Tribromide Market 2021 Business Development Strategy, Key Stakeholders and Regional Demand Analysis to 2027

Global Boron Tribromide Market 2021 Future Growth, Key Players Analysis, Regional Analysis, and Industry Forecast to 2027

Global Ultrafine Titanium Dioxide Market 2021 Industry Statistics, Key Stakeholders, Key Application, and Forecast to 2027

Global Electronic Grade Trimethyl Phosphite (TMPI) Market 2021 Industry Analysis by Application, Top-Vendor Landscape and Key Regions upto 2027

Global Trimethyl Phosphite (TMPI) Market 2021 Sales Revenue Analysis, Product Introduction, Industry Share and Forecast by 2027

Global Electronic Grade Trimethyl Phosphate (TMPO) Market 2021 Segment Overview, Regional Study, Growth Drivers, Challenges and Opportunities by 2027

Global Trimethyl Phosphate (TMPO) Market 2021 Industry Overview, Development Analysis, Strategic Outlook, Demand Analysis and Forecast by 2027

Global Electronic Grade Triethyl Phosphate (TEPO) Market 2021 Business Growing Strategies, Competitive Dynamics, Industry Segmentation and Forecast to 2027

Global Electrical BMC Market 2021 Sales Revenue Analysis, Major Manufacturers, Industry Share and Forecast 2027

Global DWDM Transceiver Market 2021 Business Insights, Emerging Opportunities with Current Trends Analysis, and Industry Development to 2027

Global Privileged Access Management (PAM) Solution Market 2021 Industry Growth, Key Vendors, Regional Outlook, Production Analysis and Forecast 2027

See more here:

Global TMS (Transcranial Magnetic Stimulation) Coil Market : Latest Innovations, Drivers and Industry Status 2021 to 2026 LSMedia - LSMedia

MINNEAPOLIS & CARMARTHENSHIRE, Wales--(BUSINESS WIRE)--Magstim, the global leader in neuroscience research and treatment for mental health, has been awarded 510K clearance for Horizon 3.0. Designed specifically for the clinical setting, Horizon 3.0 offers enhanced workflows with navigated TMS and analytics. Magstim Connect is a new powerful patient data management system for TMS delivering connected care at networked sites.

We spoke with physicians, patients, researchers and employees and asked them to imagine the next-generation of TMS technology, said Lothar Krinke, PhD, CEO Magstim. How can we improve patient care efficacy and efficiencies? Horizon 3.0 is the culmination of Magstims foundation in science, technology and our passion to improve patient outcomes.

Magstim developed the first TMS system more than 30 years ago and there have been close to 16,000 published studies citing the use of Magstim Stimulators in neuroscientific and clinical research.

TMS is a form of non-invasive brain stimulation that uses an electromagnetic coil to stimulate nerve cells in the region of the brain involved in mood control and depression.

Horizon 3.0 integrates Magstim StimGuide+, which adds new layers of quality control analytics and workflow improvements to the first FDA-cleared TMS navigation system designed for the clinical setting. Magstim Connect is an advanced new patient data management system for TMS.

Our TMS patients have experienced a high-degree of success, allowing them to change their lives, said Khaled Bowarshi, M.D., Florida TMS Clinic. We strive to provide the best technology for our patients. I can now with confidence crown Magstims Horizon 3.0 with StimGuide+ to be the best TMS system on the market today.

This FDA clearance allows Magstim to bring Horizon 3.0 to thousands of physicians and clinicians in the USA.

To learn more about Horizon 3.0 and Magstim research and clinical neurotechnology innovations, visit Magstim.com or call 844-624-7846.

About Welcony

Globally, Welcony technologies have supported thousands of research labs, clinics, hospitals and universities that focus on mental health, brain disorders, cognitive neuroscience and neuromonitoring. Key brands include Magstim Magnetic Stimulation, MagstimEGI high-density EEG, Technomed Clinical Neurophysiology and Neurosign Interoperative Nerve Monitoring. Welcony is backed by Telegraph Hill Partners, a San Francisco based private equity company.

View original post here:

Magstim Awarded FDA (510K) Clearance for Advanced Transcranial Magnetic Stimulation (TMS) Platform Horizon 3.0 - Business Wire

VANCOUVER, BC, Nov. 5, 2021 /PRNewswire/ -- Moto Transportation is now able to offer cross-border LTL (Less than a Truckload) shipping directly to GlobalTranz customers via the GlobalTranz TMS. Shippers in Texas, California, and throughout the US & Canada can work directly with Moto Transportation, Canada's LTL specialists, to move goods quickly and efficiently across the border into Canada.

"We have had a long-standing and mutually beneficial relationship with GlobalTranz," said Moto Transportation Vice-President Anastasia Petukhova. "We're proud to be integrated into their ecosystem as a service provider. We are a tech-forward company and are really impressed with their platform. We know their customers will love our cross-border offering."

While GlobalTranz has many top-tier transportation companies within their system, Moto Transportation offers direct cross-border shipping that reduces break bulk handling and transit times. This gives GlobalTranz customers major cost savings and reductions in damages.

"We are proud to partner with Moto Transportation to provide shippers a top-tier cross-border LTL solution," said Amy Cook, Director of Managed Transportation Pricing at GlobalTranz. "Their excellent on-time delivery performance and low claims ratio will serve our clients well. They are a great addition to our full-suite of logistics solutions."

Moto Transportation is recognized as one of Canada's leading cross-border, less than truckload (LTL) freight carriers. Their experience working with Canadian and US customs gives Moto Transportation a unique advantage in the supply chain marketplace. Beyond LTL offerings, Moto has a complete North American freight-forwarding and multimode offering when LTL doesn't meet the need. Moto operates terminals in Vancouver, Calgary, Toronto, San Francisco, Los Angeles, Denver, Dallas, and Houston. They are US and Canadian Customs bonded.

If you would like more information about this topic, please contact Anastasia Petukhova at 604-757-2441 or email [emailprotected]

http://www.shipmoto.com

SOURCE Moto Transportation

Go here to see the original:

Moto Transportation Is Now Listed on The GlobalTranz TMS Platform - PRNewswire

By Jim Lottsfeldt. Lottsfeldt is the publisher of The Midnight Sun.

A recall effort aimed at Mayor Dave Bronson is a terrible, no-good, stupid idea.

Nonetheless, someone will try to champion it.

It will fail.It will waste resources better spent on other efforts.And it will jeopardize the progressive majority on the Anchorage Assembly.

Mayor Bronsons approval numbers are taking a beating.He has plenty of self-inflected bruises from championing covid-19 misinformation, attacking health care workers, defending antisemitism at the Assembly hearings and taking down protective plexiglass partitions while two members of his senior staff are spreading covid-19 around an Assembly meeting. The list of self-inflicted wounds is actually much longer, but you get the point.

But that doesnt translate to success. After all, you could argue that Bronsons doing exactly what the voters wanted when they put him in office. Post-election Bronson isnt far off from pre-election Bronson.

Unfortunately, the courts have made the standard for recalls almost non-existent.So, why not use that lax standard and recall him?

The Assembly regular election is in April. Its only a few months away. Forrest Dunbar, Meg Zaletel and Kameron Perez-Verdia do not need the energy, money and attention of progressives misdirected towards a long-shot recall. Anchorage isnt New York City.Conservatives can win elections here; Dave Bronson just proved it.

Leave the recall alone unless and until Mayor Bronson does something that proves hes completely unfit to hold office. We arent there yet.We hopefully will never be there. The Anchorage Assembly should keep working with him on excellent compromises like the recently ratified homelessness plan.And when hes wrong, fight against his proposals as the Anchorage Assembly has done with success. That is the purpose of split governance.

Alaska has no scarcity of bad political ideas.So, I expect someone will run out and ask a mob to form to recall Bronson.Please dont take the bait.

Originally posted here:

TMS Publisher: Bronson Recall is misguided when Assembly races loom - The Midnight Sun

Indias credit card spending is back with a bang. It has risen consecutively for four months now. And, helped by the festive season, it crossed the Rs 80,000-crore mark in September. What is driving the overall surge? Is that indicative of a quick recovery for the larger economy? What are the lessons we can draw from this trend? Reliance Jios smartphone JioPhone Next was expected to be a disruptor that would help the company wrest control of a majority of the remaining 300 million 2G users in India. However, the phones price is a little higher than was expected, leaving analysts a tad sceptical about the smartphones potential.

Can JioPhone Next live up to its hype? A spectacular Samvat 2077 saw the Sensex playing down all the anxieties surrounding the pandemic and surging past the 62,000 mark for the first time. The Nifty also surpassed the 18,000 mark. As the year draws to a close, we take a look at how the markets fared this Samvat, which sectors sparkled on bourses, and what may be the road ahead for markets? Ethical hacking is quite a popular term now. Ethical hackers abound in real life and in fiction. But, what exactly is ethical hacking? How is it different from the other hacking we are hear about generally? Listen to these and more in todays Business Standard Morning Show podcast.

Watch video/>

Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

See original here:

TMS, Ep 35: Credit card spend, JioPhone Next, markets and ethical hacking - Business Standard

(CPT is a registered trademark of the American Medical Association (AMA))

Changes include: 1) the addition of a Category I CPT code 989X6 to report Remote Therapeutic Monitoring device supply to monitor CBT; 2) revisions to the RTM-TMS guidelines to clarify reporting of CBT; and 3) the deletion of Category III CPT codes 0X47T (permanent code 0702T to report therapeutic monitoring of a standardized online digital CBT program) and 0X81T (permanent code 0703T to report the associated management services).

These revisions, which will go into effect as of January 1, 2023, will allow for the reporting of CBT monitoring services as part of RTM/RTM-TMS on a monthly basis. Meanwhile, Category I RTM/RTM-TMS CPT codes that describe services related to remote monitoring of therapy adherence and therapy response, will be available starting on January 1, 2022.

In some instances, providers may elect to use remote monitoring to help manage patients receiving remote therapy through digital medical tools like Pears FDA-authorized PDTs including reSET, reSET-O, and Somryst that deliver treatment of substance use disorder, opioid use disorder, and chronic insomnia, respectively, including the healthcare providers ability to remotely monitor therapeutic progress.

BOSTON, November 04, 2021--(BUSINESS WIRE)--Pear Therapeutics, Inc. is pleased to share that the American Medical Association (AMA) Current Procedural Terminology (CPT) Editorial Panel has announced revisions to existing CPT codes clarifying the coding of remote therapeutic monitoring for cognitive behavioral therapy (CBT) services. These changes include: 1) the addition of CPT code 989X6 to report Remote Therapeutic Monitoring device supply to monitor CBT; 2) revisions to the Remote Therapeutic Monitoring (RTM) and Remote Therapeutic Monitoring Treatment Management Services (RTM-TMS) guidelines to clarify reporting of CBT; and 3) the deletion of Category III CPT codes 0X47T (permanent code 0702T to report therapeutic monitoring of a standardized online digital cognitive behavioral therapy program) and 0X81T (permanent code 0703T to report the associated management services).

Story continues

These changes have an effective date of January 2023 CPTs Summary of Panel Actions for September-October 2021 may be found here: https://www.ama-assn.org/system/files/september-october-2021-summary-of-panel-actions.pdf.

Meanwhile, Category 1 RTM and RTM-TMS CPT codes, which were first announced in 2020, will be available starting on January 1, 2022, to describe physician and other qualified healthcare professional work including monitoring therapy adherence and response. These codes may be applicable to the work of HCPs monitoring therapy adherence and therapy response with respect to Pears commercially available PDTs, reSET, reSET-O and Somryst for the treatment of substance use disorder, opioid use disorder, and chronic insomnia, respectively, including the healthcare providers ability to remotely monitor progress.

Appropriate billing and coding for healthcare services are the providers responsibility and should always be based on the patients clinical condition, services provided, and payer guidelines. A comprehensive review of all recent changes related to remote therapeutic monitoring is recommended.

"AMAs clarifications and addition to codes describing services related to clinician monitoring of FDA-authorized medical devices delivering Cognitive Behavioral Therapy (CBT) are another significant milestone in providing coding for healthcare providers across the United States," said Corey McCann, M.D., Ph.D., President and Chief Executive Officer of Pear Therapeutics. "Ultimately, RTM Category 1 codes will provide additional CPT coding options for healthcare providers when using digital health technologies."

On October 29, 2021, AMA released the CPT Editorial Summary of Panel Actions (https://www.ama-assn.org/system/files/september-october-2021-summary-of-panel-actions.pdf), which reflects the discussion at the most recent CPT Editorial Panel meeting in September 2021. CPT coding serves as a uniform nomenclature used for medical services to improve harmonization of reporting, increase the accuracy of medical services and procedures, and to improve efficiency across healthcare. CPT terminology is the most widely accepted medical language for public and private health insurance programs. The CPT Editorial Panel is tasked with maintaining an open process that convenes meetings to solicit input from stakeholders across healthcare.

AMA announced their CPT Editorial Panel accepted the addition of code 989X6 to report remote therapeutic monitoring device supply to monitor cognitive behavioral therapy; the revision of the Remote Therapeutic Monitoring Services guidelines and the Remote Therapeutic Monitoring Treatment Management Services guidelines (CPT code family 98975, 98976, 98977, 98980, and 98981) to clarify reporting of cognitive behavioral therapy; and the deletion of codes 0X47T, 0X81T (now permanent codes 0702T and 0703T).

PDTs are a new therapeutic class that use software to treat serious disease. Like traditional medicines, PDTs are developed in a Good Manufacturing Practices (GMP) compliant environment, tested in randomized controlled trials to demonstrate safety and effectiveness, evaluated for authorization by regulators like FDA, and used under the supervision of a prescribing clinician. Pears PDTs are designed to collect real world data for use by prescribing clinicians and for population health management by payers and health systems.

About Pear Therapeutics

Pear Therapeutics is the leader in prescription digital therapeutics, or PDTs. Pear aims to redefine medicine by discovering, developing, and delivering clinically validated software-based therapeutics to provide better outcomes for patients, smarter engagement and tracking tools for clinicians, and cost-effective solutions for payers. Pear has a portfolio of products and product candidates across therapeutic areas, including the first three PDTs with disease treatment claims from FDA. Pears lead product, reSET, for the treatment of substance use disorder, was the first PDT to receive marketing authorization from FDA to treat disease. Pears second product, reSET-O, for the treatment of opioid use disorder, was the first PDT to receive Breakthrough Designation. Pears third product, Somryst, for the treatment of chronic insomnia, was the first PDT submitted through FDAs traditional 510(k) pathway while simultaneously reviewed through FDAs Software Precertification Pilot Program. For more information, visit Pear at http://www.peartherapeutics.com.

reSET Important Safety Information

Indications for Use:

reSET is intended to provide cognitive behavioral therapy, as an adjunct to a contingency management system, for patients 18 years of age and older, who are currently enrolled in outpatient treatment under the supervision of a clinician. reSET is indicated as a 12-week (90 day) prescription-only treatment for patients with substance use disorder (SUD), who are not currently on opioid replacement therapy, who do not abuse alcohol solely, or who do not abuse opioids as their primary substance of abuse.

It is intended to:

increase abstinence from a patients substances of abuse during treatment, and

increase retention in the outpatient treatment program.

Important Safety Information for Clinicians:

Warnings: reSET is intended for patients whose primary language is English with a reading level of 7th grade or above, and who have access to an Android/iOS tablet or smartphone. reSET is intended only for patients who own a smartphone and are familiar with use of smartphone apps (applications).

Clinicians should not use reSET to communicate with their patients about emergency medical issues. Patients should be clearly instructed not to use reSET to communicate to their clinician any urgent or emergent information. In case of an emergency, patients should dial 911 or go to the nearest emergency room.

reSET is not intended to be used as a stand-alone therapy for substance use disorder (SUD). reSET does not replace care by a licensed medical practitioner and is not intended to reduce the amount of face-to-face clinician time. reSET does not represent a substitution for a patients medication. Patients should continue to take their medications as directed by their healthcare provider.

Patients with substance use disorder experience mental health disease and co-morbid medical problems at higher rates than the general population. Patients with substance use disorder also have higher baseline rates of suicidal ideation, and suicide attempts, and suicide completion. Clinicians should engage in their normal care practices to monitor patients for medical problems and mental health disorders, including risk for harming others and/or themselves.

The long-term benefit of treatment with reSET on abstinence has not been evaluated in studies lasting beyond 12 weeks (90 days) in the SUD population. The ability of reSET to prevent potential relapse after treatment discontinuation has not been studied.

The effectiveness of reSET has not been demonstrated in patients currently reporting opioids as their primary substance of abuse.

This Press Release does not include all the information needed to use reSET safely and effectively. Please see the Clinician Brief Summary for reSET for more information.

reSET-O Important Safety Information

Indications for Use:

reSET-O prescription digital therapeutic is a 12-week (84 day) software application intended to increase retention of patients with opioid use disorder (OUD) in outpatient treatment by providing cognitive behavioral therapy, as an adjunct to outpatient treatment that includes transmucosal buprenorphine and contingency management, for patients 18 years or older who are currently under the supervision of a clinician. reSET-O is indicated as a prescription-only digital therapeutic.

Important Safety Information for Clinicians:

Warnings: reSET-O is intended for patients whose primary language is English with a reading level of 7th grade or above, and who have access to an Android/iOS tablet or smartphone. reSET-O is intended only for patients who own a smartphone and are familiar with use of smartphone apps (applications).

Clinicians should not use reSET-O to communicate with their patients about emergency medical issues. Patients should be clearly instructed not to use reSET-O to communicate to their clinician any urgent or emergent information. In case of an emergency, patients should dial 911 or go to the nearest emergency room.

reSET-O is not intended to be used as a stand-alone therapy for Opioid Use Disorder (OUD). reSET-O does not replace care by a licensed medical practitioner and is not intended to reduce the frequency or duration of in-person therapy. reSET-O does not represent a substitution for a patients medication. Patients should continue to take their medications as directed by their healthcare provider.

Patients with opioid use disorder experience mental health disease and co-morbid medical problems at higher rates than the general population. Patients with opioid use disorder have higher baseline rates of suicidal ideation, and suicide attempts, and suicide completion. Clinicians should undertake standard of care to monitor patients for medical problems and mental health disease, including risk for harming others and/or themselves.

The long-term benefit of reSET-O has not been evaluated in studies lasting beyond 12 weeks (84 days) in the OUD population. The ability of reSET-O to prevent potential relapse after therapy discontinuation has not been studied.

This Press Release does not include all the information needed to use reSET-O safely and effectively. Please see the Clinician Brief Summary Instructions for reSET-O for more information.

Somryst Important Safety Information

Indications for Use

Somryst is a prescription-only digital therapeutic intended to provide a neurobehavioral intervention (Cognitive Behavioral Therapy for Insomnia CBT-I) to patients 22 years of age and older with chronic insomnia. Somryst treats patients with chronic insomnia by improving a patients insomnia symptoms.

Important Safety Information:

Warnings: Somryst is not for everyone. Please use your clinical judgement to determine whether Somryst is right for your patient.

Somryst is not for emergency use. Please instruct patients to dial 911 or to go to the nearest emergency room in the event of a medical emergency,

Patients should be clearly instructed not to use Somryst to communicate severe, critical, or urgent information to their Health Care Provider.

Somryst is not meant to be used as treatment without supervision of a Health Care Provider.

Somryst is not meant to be a substitution for any treatment medication.

Somryst contains sensitive medical information. Please instruct patients to protect their information by password-protecting their smartphone and tablet, ensuring no one else may access their device.

Sleep Restriction (and Consolidation) within Somryst can cause sleepiness, especially in the early stages of using the PDT. Somryst should not be used if the patient needs to be alert or cautious to avoid serious accidents in their job or daily life. Examples include:

The usage data collected in therapy lessons by Somryst are not intended to be used as a standalone assessment of treatment progress.

This press release does not include all the information needed to use Somryst safely and effectively. Please see the full Clinician Brief Summary Instructions for Somryst for more information.

View source version on businesswire.com: https://www.businesswire.com/news/home/20211104005650/en/

Contacts

Media and Investors: Meara MurphySenior Director, Corporate Communicationsmeara.murphy@peartherapeutics.com

View post:

Pear Therapeutics Announces Milestone Decision by the American Medical Association CPT Editorial Panel to Clarify the Coding of Remote Therapeutic...

HARRISON COUNTY, Ohio (WTRF) When veterans return home from combat, sometimes theyre left with more than memories.That can be a physical injury or a mental scar that we cant see, but wont go away.

But, what happens when a veteran feels like theres no help left?

22 veterans a day commit suicide.

Inside a small room in Harrison County, theyre taking the first steps to reduce that number.

Were trained in the military to suck it up and drive on and its a good concept in battle.

However, its not always when it comes to readjusting from combat to the comforts of home.

30 days. Thats a very short amount of time to get the rest of your life back.

The dull humming of the TMS machines inside a small room at the Harrison County Sheriffs Office is a welcome noise to area veterans.

What theyre doing is kinda pressing control alt delete in the brain and were re-booting it. Were slowing the neurons down or speeding them so that both sides of the brain are working at their optimum level.

Its called transcranial magnetic stimulation and its helping veterans with PTSD, brain injuries, and much more.

TMS works with a magnet. Those wishing to receive the treatment get an initial EEG to test how their brain waves are functioning. Then, that number is sent to a treatment center in California. The time and intensity of the treatments is adjusted based on each persons unique brain rhythm with guidance from the treatment center.

About 35 veterans have completed the program in Harrison County. It takes 30 minutes a day, five days a week for six weeks for a total of 30 treatments.

I felt a tingle go down my hands and Ive never been able to close my hands for years and years and right then I closed a complete fist without any problem.

Terry Fabry of Smithfield is a Vietnam veteran. When 7News spoke to him, he only had one more session left to finish his TMS treatment. Before it helped improve his life, Fabry had trouble sleeping and was in pain most of the time.

When I was over there I fell down a mountain and I was carrying a radio and I had my M-79, which carries 68 rounds and it was a lot of weight. When I fell down the mountain I fell probably 20, 30 feet and I rolled into a cave and screwed up my neck, my lower back and my ankle. Everything from that time hasnt been good.

Fabry said he saw results after the first session.

I am proud of what I did. I did what I thought I should do at the time and Ive just had to live with the aftermath.

Roy Stewart is a Vietnam veteran who lives in St. Clairsville.

He said hes struggled mentally for years, especially with sleep after his wife died.His stepson, also a veteran, sustained a head injury during service.

I am sleeping better. I havent quite got all the way yet, because Im starting my third treatment now, but its worth it because I feel better and my stepsons doing better.

Spend time with the group that frequently gathers at the Harrison County Sheriffs Office and theyll tell you how much TMS changed their lives.

Its not just for veterans. The treatment is FDA approved for headaches and anxiety.

There are around 50 of these TMS machines in the world, and two of them reside in Harrison County. People from 11-years-old all the way to 93-years-old have gotten the treatments.

I feel like this has made me more at ease. Its made me more comfortable.

Dirk Harkins sets up these machines five days a week.He works so hard to help others because he knows how TMS can change a life.

I found myself in a high-speed chase with local law enforcement agencies and I pulled over and tried suicide by cop at that time.

In this Digital Exclusive, hear veteran Dirk Harkins describe the difficult journey after an injury and PTSD diagnosis that lead him to TMS treatments and how they changed his life.

Harkins served in the Army in the 82nd Airborne and was injured in 2007 when a Humvee he was riding in was hit with an IED. He suffered back, neck and hip injuries, was diagnosed with a traumatic brain injury (TBI) and PTSD. Harkins returned home and was never the same.

He was stuck in a days-long depression, after years of struggles with opioids and alcohol and Harkins recalls he was at the end of his rope.

After seeking help at the V.A. and told to come back in a few days, he found himself in that encounter with police and eventually in jail. There Harkins called his friend, Ohio State Senator Frank Hoagland, who got him into TMS treatments in Texas for six months.

For 12 years I was having a headache every single day at one level or another I would wake up with a headache. Throughout the week I would probably have two to three maybe four migraines where they would put me down and Id have to rely on medication and sleep to try and get rid of these migraine headaches, but after the fourth treatment I woke up for the first time in 12 years and didnt have a headache. If that was all that happened to me I would of come back to Ohio excited, you know what I mean, but it started doing other things. Its started giving me clarity. It gave me mental focus and energy and started giving me my life back.

He now channels that energy into getting more TMS treatments to veterans in the Buckeye State.Working with Senator Hoagland and local sheriffs departments, they want to make sure its available to anyone, anywhere who needs it.

Harkins said hes already began that initial EEG on several veterans and first responders in Noble County to set up the next treatment site.

Its gonna start right here in the Ohio Valley and its going to spread out across the state.

If youre a veteran or first responder and would like to learn more about TMS and what it does, you can call Dirk Harkins at 740-491-7125.

More here:

30 days, life-changing results: The new treatment available to veterans in the Ohio Valley - WTRF

Its zanier, brainier, and insanier. Warner siblings Yakko, Wakko, and Dot have returned for the brand-new Season 2 of Steven Spielbergs rebooted cartoon comedy series, Animaniacs, now airing on Hulu. The wild and wacky animated variety show originally ran for five seasons before wrapping in 1998. Over two decades later, Warner Bros. has brought back the Emmy Award-winning series, with Family Guys Wellesley Wild serving as showrunner and executive producer along with Spielberg and Kung Fu Panda: Legends of Awesomeness Gabe Swarr.

Other executive producers include President of Warner Bros. Animation Sam Register as well as Amblin Television Co-Presidents Darryl Frank and Justin Falvey. The new seasons antics range from historical quips and bits, to riffs on Netflix and outer space excursions. Season 2s 13 episodes also feature previously rejected Animaniacs characters and, according to Swarr, are filled with even more earworm songs that viewers just won't be able to get out of their heads.

The best part about working on this show is being able to go anywhere and do anything, says the EP. We're so thankful and grateful for this opportunity. And Steven has been our guiding light.

But when first approached about rebooting the series, Swarr initially declined.

I actually said no a couple times to doing the show because I was really worried about the fans and if we would do a good job or not, he explains. Animaniacs has had such a loyal following, so I was very apprehensive.

Even though Swarr says he was part of the Ren & Stimpy camp during the shows original run, he was very familiar with the popularity of the series and didnt want to do wrong by the fans. He finally got on board after realizing that rebooting Animaniacs gave him a long-awaited opportunity that he likely wouldnt get again.

I love variety shows, says Swarr. I always wanted to do a variety show like Monty Python or The Muppet Show. But its so hard to do that in animation and I figured this was going to be my only opportunity to ever do it. I tried to pitch a variety show a bunch of times and it was always a really hard sell because there's never a built-in audience. And this is the one time where you could do it with a built-in audience. Plus, I'm kind of smart-assy too, which is the perfect attitude for Animaniacs.

Rebooting a series in 2020 thats known for its unapologetic stabs at pop-culture certainly was a hefty task, and Swarr says it took a lot of research for the team to initially get their footing. We went back and watched nearly every episode from the original series, he shares. There are definitely certain things that aren't as woke anymore, and we didn't want to lean into that at all. But we also wanted to make commentary on everything we could.

From streaming subscriptions to Gladiator film quotes, Animaniacs touches not just on current topics, but older references for older viewers as well. Afterall, just like the original series, the bits arent just for the kids.It is walking that fine line, confirms Swarr. The original show was set up to be for family viewing. It wasnt just for kids, and it wasn't just for adults. In the beginning of the production on the reboot, we were brought in and told, Okay, here's the show, and your target audience is 10 to 25. Thats a wide range and its amazing getting to put jokes in a show that go over kids heads, but then also keep all the slapstick for the younger audience.

He adds, Were always straddling between those two features. But finding that balance not only makes the show better, but its also where the show needs to be.

Though most of the jokes are new - or jokes about doing worse versions of old jokes from the original series - the animation should feel extremely familiar. Swarr says that he and the team took great care in producing animation as close to the original as possible.

We wanted to style the new series off the best of the original, and as the original show went on, the animators got better and better at drawing the characters, Swarr reveals. Certain studios Warner Bros. had worked with in the past really stood out to us. My favorite one was the Japanese studio called TMS, Tokyo Movie Shinsha. I had a chance to interview one of the directors from that studio who worked on the original Animaniacs and got to ask every question I could. After talking with them, it was very obvious the studio had been doing their own thing and their own take on these characters - simplifying their anatomy, changing the proportions a little bit, making them more streamlined. So thats what we did, looking at how TMS interpreted the Warner Bros. models, and went from there.

Leaning into the classic hand-drawn, 2D style, Swarr says their team set up the visuals to be as exactly like the original as we could, avoiding modern tricks like After Effects blurs.

He continues, We're really trying to show off that original look and do it in the most traditional way possible.

But, like any good variety show, tradition hasnt stopped Swarr and the production team from adding in a few visual surprises in the second season.

We go to a lot more places visually in this season than in Season 1, he says, careful not to give too much away for the sake of surprise. This show is almost like a playground where I can just play visually with different mediums of animation and animation styles. We definitely took advantage of that in this season.

Animaniacs was also renewed for a third season shortly after the first season released, and Swarr says its been a blessing as far as way the show is staffed and produced. Season 3 is our first chance to really react to what the audience thought about the first season, because the first and second seasons were all done at the same time he says. Which is why we didn't want to lose our first season writers and artists. That's always what you're always up against with TV. And the DNA of the show really changes if you can't keep the same crew. You'll lose the tone. That's the hardest part. So, aside from wanting the show to continue, that was a big reason we were really excited to be picked up for more seasons so early.

Now, Swarr and the rest of the crew have their fingers crossed that the Animaniacs hijinks continue with a Season 4 pick-up. Wed really love to keep everyone on board and keep going, says Swarr. All the writers are amazing, and everyone just comes up with so many great ideas. And then hopefully, with the fourth season, we will have some ideas from audiences' reactions to Season 2.

Victoria Davis is a full-time, freelance journalist and part-time Otaku with an affinity for all things anime. She's reported on numerous stories from activist news to entertainment. Find more about her work at victoriadavisdepiction.com.

Read the rest here:

Yakko, Wakko, and Dot Return: 'Animaniacs' Season 2 Mayhem Arrives! - Animation World Network